OXT and obesity due to melanocortin 4 receptor deficiency: Early on the fight against SARS-CoV-2, scientists considered oxytocin as a potential therapeutic molecule, since it holds the ability to alleviate diseases such as cardiovascular entities, obesity and diabetes, which put covid patients at higher risk.